Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ampio Pharmaceuticals Inc AMPE

Healthcare
Ampio Pharmaceuticals, Inc. is a drug discovery and development company. The Company is focused on combining scientific, clinical, and manufacturing capabilities to develop therapies aimed at treating conditions for which limited treatment options exist.

Recent & Breaking News (OTCPK:AMPE)

Ampio Completes Enrollment of Patients in 12-Week Pivotal Trial

PR Newswire September 18, 2017

Ampio Pharmaceuticals, Inc. Announces Annual Shareholder Meeting

PR Newswire September 8, 2017

Ampio Pharmaceuticals, Inc. to Present at the 19th Annual Rodman & Renshaw Global Investment Conference

PR Newswire September 7, 2017

Ampio Discloses Receipt of Notice from NYSE American and Has Until March 1, 2019, to Gain Compliance

PR Newswire September 7, 2017

Daily Technical Summary Reports on Biotech Stocks -- Axovant Sciences, Ampio Pharma, ImmunoCellular Therapeutics, and Synthetic Biologics

PR Newswire August 9, 2017

Ampio Announces the Allowance of a Composition and Methods Patent in the USA Using Ampion™ in Conjunction with Stem Cells

PR Newswire August 8, 2017

Ampio Hosting Conference Call, Wednesday, July 12, 4:30 pm EDT

PR Newswire July 6, 2017

Ampio Injects First Patient in Final Pivotal Clinical Trial for Ampion™ BLA

PR Newswire June 22, 2017

Ampio Announces Appointment of Interim Chief Financial Officer

PR Newswire June 12, 2017

Ampio Pharmaceuticals, Inc. Announces Closing of Registered Direct Offering

PR Newswire June 7, 2017

Ampio Pharmaceuticals, Inc. Announces Pricing of Registered Direct Offering

PR Newswire June 2, 2017

Ampion™ Human Macrophage Study Results Accepted for Presentation at the 2017 Annual AAST Meeting in Baltimore

PR Newswire May 5, 2017

Ampio Initiates Pivotal Trial of Ampion™

PR Newswire May 1, 2017

Ampio Pharmaceuticals Amends Warrant Agreement

PR Newswire March 28, 2017

Ampio Updates Intellectual Property and Regulatory Exclusivity Strategy to Support the Commercialization of Ampion™

PR Newswire March 23, 2017

Update - Ampio Pharmaceuticals Provides Corporate Update

PR Newswire March 22, 2017

Ampio Pharmaceuticals Provides Corporate Update

PR Newswire March 20, 2017

Ampio Hosting Conference Call Tuesday, March 7, 4:30pm EST

PR Newswire March 1, 2017

Ampio Receives Guidance from the FDA and Proposes a Path for Approval for Single-Injection Ampion™ for the Treatment of Pain Due to Severe Osteoarthritis of the Knee

PR Newswire February 27, 2017

Ampio Updates Clinical and Regulatory Activity

PR Newswire November 10, 2016